News

STAT1dOpinion
The life-and-death stakes of RFK Jr.’s decision to remake a vaccine panel
Take a moment to consider the stakes involved in health secretary Robert F. Kennedy's remake of a vaccine advisory committee.
Kennedy’s new CDC panel includes members who have criticized vaccines, spread misinformation
RFK dismissed the CDC's scientific vaccine advisers. His appointees for replacements are raising concerns about vaccine ...
RFK Jr’s shakeup of vaccine advisory committee raises worries about scientific integrity of health recommendations
The Advisory Committee on Immunization Practices guides the CDC’s hand on vaccine policy, but some of its new members have ...
RFK Jr. taps eight new members for CDC's vaccine advisory panel
The new members include well-known vaccine skeptics and others who have been critical of Covid vaccines or pandemic ...
RFK Jr. appoints 8 new members to CDC's vaccine advisory committee, including some critics of shots
Robert F. Kennedy Jr. announced on Wednesday eight new members of the CDC's independent vaccine advisory committee, some of ...
Capricor says FDA inspection brought Form 483 with several observations
Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San ...
Capricor: A Hold Rating With Regulatory FDA Form Given For Deramiocel Advancement
Capricor Therapeutics' rating was downgraded amid FDA inspection risks, regulatory uncertainty, and potential delays in ...
TipRanks on MSN3d
H.C. Wainwright says Capricor path to approval ‘sharpens’ with inspection done
H.C. Wainwright notes that Capricor Therapeutics (CAPR) announced that the FDA has completed its pre-license inspection of the company’s San Diego ...
Investing.com Australia3d
Capricor Therapeutics stock falls after FDA inspection of manufacturing facility
Investing.com -- Capricor Therapeutics Inc (NASDAQ: CAPR) stock tumbled 10.5% after the company announced that the FDA’s inspection of its San Diego manufacturing facility resulted in a Form 483 with ...
The Manila Times3d
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support ...